Newron Pharmaceuticals S.p.A. (FRA:NP5)

Newron Pharmaceuticals Revenue

Newron Pharmaceuticals had revenue of 11.90M EUR in the half year ending June 30, 2025, with 116.56% growth. This brings the company's revenue in the last twelve months to 59.88M, up 759.12% year-over-year. In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M with 467.41% growth.

• Revenue (ttm): 59.88M
• Revenue Growth: +759.12%
• P/S Ratio: 6.94
• Revenue / Employee: 2.72M
• Employees: 22
• Market Cap: 415.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	51.39M	42.33M	467.41%
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%
Dec 31, 2020	5.26M	-1.78M	-25.29%